Genmark Diagnostics Earnings: Your Sneak Peek to the Big Announcement

Genmark Diagnostics (NASDAQ:GNMK) will report earnings after markets close on Wednesday, May 8th. GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The Company’s system supports a broad range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges.

Here is your Cheat Sheet to Genmark Diagnostics Earnings:

Earnings Expectations: Analysts expect earnings of $-0.17 per share on revenues of $9.56 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.13 to a loss $0.21. For the current year, the average estimate is a loss of $0.8, which is the same as the estimate ninety days ago.

Earnings Trends:

Here’s how Genmark Diagnostics has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 0.65 1.00 2.56 5.01 20.47
Diluted EPS ($) -28.13 -4.41 -1.88 -1.45 -0.84

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 2.03 2.16 3.61 5.26 9.44
Diluted EPS ($) -0.2703 -0.28 -0.26 -0.20 -0.1478

Past Performance:
Genmark Diagnostics has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]